Literature DB >> 2468411

Methotrexate neurotoxicity: in vitro studies using cerebellar explants from rats.

M R Gilbert1, B L Harding, S A Grossman.   

Abstract

The mechanism of methotrexate (MTX)-induced neurotoxicity was investigated using cerebellar explant cultures from fetal rats. After 3 weeks of growth, myelinated cultures were treated with MTX at 1 microM, lysolecithin at 1 mg/dl, or unaltered nutrient medium. Myelin sheaths devoid of axons were observed by histological and electron microscopic preparations after 2 weeks of MTX exposure. After 5 weeks, cultures were almost entirely devoid of myelin sheaths. Myelin basic protein in the media removed from the cultures showed an increase in concentration after 3 weeks of MTX exposure and was significantly greater than control after 5 weeks of exposure. 2',3'-Cyclic nucleotide 3'-phosphohydrolase activity, a measure of oligodendroglial function, was not significantly different in the MTX group compared to controls. Lysolecithin-treated cultures showed widespread destruction and an early increase in myelin basic protein release into the medium. These data indicate that, in the cerebellar explant cultures, MTX is primarily a neuronal toxin, and the demyelination is a consequence of axonal loss and is not related to a change in oligodendroglial cell function. These findings provide new insight into the pathogenesis of MTX-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468411

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Intracerebral (parenchymal) infusion of methotrexate: report of a case.

Authors:  K A Page; H Vogel; D S Horoupian
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

2.  The intracerebral penetration of intraventricularly administered methotrexate: a quantitative autoradiographic study.

Authors:  S A Grossman; C S Reinhard; H L Loats
Journal:  J Neurooncol       Date:  1989-11       Impact factor: 4.130

3.  The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester.

Authors:  Ertugrul Uzar; Hasan Rifat Koyuncuoglu; Efkan Uz; H Ramazan Yilmaz; Suleyman Kutluhan; Serkan Kilbas; Fatih Gultekin
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

4.  Irreversible paraplegia following one time prophylactic intrathecal chemotherapy in an adult patient with acute lymphoblastic leukemia.

Authors:  Hea Yong Lee; Sung-il Im; Myoung-Hee Kang; Kwang Min Kim; Seok Hyun Kim; Hun-Gu Kim; Jung Hun Kang; Gyeong-Won Lee
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

5.  Breast cancer leptomeningeal metastasis--the role of multimodality treatment.

Authors:  Halina Rudnicka; Anna Niwińska; Magdalena Murawska
Journal:  J Neurooncol       Date:  2007-02-20       Impact factor: 4.506

6.  The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series.

Authors:  Andrea Santangelo; Emanuele Bartolini; Giulia Nuzzi; Thomas Foiadelli; Alexandre Michev; Tommaso Mina; Irene Trambusti; Valeria Fichera; Alice Bonuccelli; Gabriele Massimetti; Diego G Peroni; Emanuela De Marco; Luca Coccoli; Laura Luti; Sayla Bernasconi; Margherita Nardi; Maria Cristina Menconi; Gabriella Casazza; Dario Pruna; Rosamaria Mura; Chiara Marra; Daniele Zama; Pasquale Striano; Duccio M Cordelli; Roberta Battini; Alessandro Orsini
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

7.  Neurotoxicity of cancer chemotherapy.

Authors:  Miyoung Yang; Changjong Moon
Journal:  Neural Regen Res       Date:  2013-06-15       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.